GlaxoSmithKline Fined $3 Billion

(2:11)

GlaxoSmithKline CEO: Pursuing Drug Approvals | Mad Money | CNBC

(9:47)

Is GlaxoSmithKline a Top Pharma Stock? | $GSK Stock Analysis

(11:24)

GlaxoSmithKline to Pay $3 Billion Fine

(1:34)

GSK – Our story

(3:57)

Bad Medicine: The Glaxo Case

(13:16)

GlaxoSmithKline involved in a corruption scandal in China

(1:29)

Drugmaker GlaxoSmithKline 'guilty of fraud'

(2:5)

Glaxo Gets Ready to Split in Two

(6:39)

glaxo smith kline | glaxosmith pharma top interview questions and answers for freshers / experienced

(16:39)

BSR Conference 2014: Sir Andrew Witty, CEO GlaxoSmithKline

(55:47)

Disturbing Interview With Andrew Witty (GSK)

(9:9)

The David Rubenstein Show: GSK CEO Emma Walmsley

(24:6)

GSK Demerger Explained

(9:49)

GlaxoSmithKline ($GSK) - Quick Stock Analysis

(6:46)

THE FTSE SHOW 024 | Glaxosmithkline plc - This pharmaceutical giant a good long term growth stock?

(23:33)

GlaxoSmithKline (GSK) Fined $3 Billion

(6:35)

Pharmaceutical Factory Shoot - GSK Nashik Corporate Induction Video Film

(8:45)

GlaxoSmithKline announces $300 million equity investment in 23andMe

(3:28)

GSK Story

(3:10)

GlaxoSmithKline Found Guilty of Bribery in China

(1:58)

GSK CEO Emma Walmsley on beating Q4 earnings

(4:47)

Is GSK PLC Stock a Buy Now in 2024? | GlaxoSmithKline PLC (GSK) UK Stock Analysis | Full Valuation

(9:30)

BVTV: GSK’s big breakup

(1:19)

The GSK story

(3:38)

GlaxoSmithKline on Vaccines

(4:54)

Here’s How GlaxoSmithKline Is Able to Turn a Profit

(2:33)

Is GlaxoSmithKline a Buy Now!? | GSK Stock Analysis

(5:28)